Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: -0.25 (-1.37%)
Spread: 1.00 (5.714%)
Open: 18.25
High: 19.00
Low: 17.85
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Manufacturing, supply & profit sharing agreement

1 Nov 2017 07:00

RNS Number : 1441V
OptiBiotix Health PLC
01 November 2017
 



OptiBiotix Health plc

("OptiBiotix" or the "Company")

 

Manufacturing, supply and profit sharing agreement with Knighton Foods

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a manufacturing and supply agreement with Knighton Foods, ("Knighton"). The agreement grants Knighton an exclusive licence to manufacture and supply OptiBiotix's SlimBiome® weight management technology in the United Kingdom, in return for 50% of the profit, with an agreed cost of manufacture and minimum sales price per kilogramme.

 

Knighton, a wholly owned subsidiary of Premier Foods plc, is a leading producer of a wide range of high quality, value adding, functional powdered foods, specialist ingredients and finished products, to some of the countries major supermarkets, high street coffee houses, and best-known household brands. Knighton's advanced powder technology was key to developing an improved version of SlimBiome®, providing enhanced solubility and better product presentation, greatly improving flavour and mouthfeel.

 

SlimBiome®, a patented combination of natural ingredients developed by experts to provide hunger free weight loss, will be supplied by Knighton as a specialised functional ingredient, into a wide range of finished products for use in the retail, vending, and ingredients sectors. Knighton will use their best endeavours to promote and expand the supply of SlimBiome®, bringing it to the attention of product innovation teams across their wide range of customers.

 

This agreement, with one of the UK's leading specialist ingredients suppliers, is an important step in optimising the supply chain by leveraging Knighton's purchasing power, manufacturing efficiencies and partner network to scale up the manufacture and supply of SlimBiome®.  This is an important step to meet the needs of major UK retailers and exports of SlimBiome®, and SlimBiome® containing products to Tata, and potential new partners, in the Iarge consumer markets of India and the USA.

 

Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce the signing of a manufacturing, supply and profit sharing agreement with Knighton Foods. We chose Knighton due to their world leading expertise in adding value and differentiation to speciality powdered ingredients like SlimBiome®. Their development work greatly improved SlimBiome's solubility, taste and mouthfeel whilst reducing the overall cost of manufacture. We believe working with Knighton, and similar partners around the world, provides the best opportunity of meeting the requirements of major retailers and the growing interest we are seeing in SlimBiome® from partners worldwide."

 

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

Cairn Financial Advisers LLP (NOMAD)

Tel: 020 7213 0883

Liam Murray

 

FinnCap (Broker)

 

Tel: 020 7220 0500

Adrian Hargrave / Scott Mathieson / Kate Bannatyne (Corporate Finance)

Tony Quirke (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

About OptiBiotix - www.optibiotix.com 

 

OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

 

The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. 

 

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.

 

About Knighton Foods www.knightonfoods.com

 

Knighton Foods, based in the U.K are a leading producer of high quality specialist powdered products. Their suite of processes includes, processing, blending and packaging capabilities ranging from portion controlled sachets to 1 ton bulk containers. 

Knighton's technical and R&D capabilities have been developed over 100+ years' and deliver value and functionality to ingredients and finished products, for use in the Retail, Out of Home, and Ingredients sectors. Examples of which can be found on the shelves of the UK's leading supermarkets in some of the most recognised consumer brands, and leading chains of fast food restaurants and coffee shops.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREFLFXDBFBFBX
Date   Source Headline
3rd Feb 20144:31 pmRNSFurther re Open Offer
30th Jan 20144:37 pmRNSOffer Document Posted
30th Jan 20144:36 pmRNSAnnual Financial Report
28th Nov 20137:00 amRNSChange of Name
26th Nov 20137:00 amRNSChange of Rule 26 Website Address
25th Nov 201311:57 amRNSHolding(s) in Company
20th Nov 20131:21 pmRNSHolding(s) in Company
18th Nov 201312:53 pmPRNNotice of GM and Directorate Change
1st Nov 20134:05 pmPRNPosting of Circular
8th Aug 20137:00 amPRNUpdate
2nd Aug 20137:00 amPRNIssue of Equity - Conversion of Debt, Directors Dealing
25th Apr 20137:00 amPRNHalf-yearly Report
14th Mar 201311:19 amPRNResult of AGM, General Meeting and Issue of Equity
19th Feb 20137:00 amPRNNotice of General Meeting, AGM and Placing
31st Jan 20133:09 pmPRNFinal Results
6th Dec 201212:38 pmRNSNew Contract Win
15th Oct 20128:21 amRNSNew Product Approvals
12th Oct 20127:00 amPRNUpdate and Directorate Changeange
14th Sep 201211:30 amRNSProduct Approval
6th Sep 20127:00 amPRNNew Product Sales
3rd Sep 201210:54 amPRNChange of Adviser
3rd Sep 20128:55 amRNSNew Product Announcement
2nd Jul 20123:56 pmPRNTotal Voting Rights
18th Jun 201211:49 amPRNResult of General Meeting
14th Jun 201210:32 amPRNFurther re placing, update and grant of options
1st Jun 20123:22 pmPRNTotal Voting Rights
24th May 20127:00 amPRNPosting of Circular and change of registered office
22nd May 201211:30 amPRNPlacing and update
30th Apr 201212:00 pmPRNHalf-yearly Report
29th Feb 20121:20 pmPRNTotal Voting Rights
8th Feb 20127:01 amPRNIssue of Equity
8th Feb 20127:00 amPRNTrading Update
24th Jan 20127:00 amPRNHolding(s) in Company
19th Dec 201112:10 pmPRNResult of Annual General Meeting and Statement
2nd Dec 20117:00 amPRNDirectorate change and update
31st Oct 20112:16 pmPRNPosting of report and accounts
28th Oct 20117:00 amPRNFinal Results
23rd Sep 201110:38 amPRNShare Price Movement and Update
9th Sep 20117:00 amPRNFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.